Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 150 participants.
Also called NCT03635424
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT03635424
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03635424. Allocation not applicable; no masking; primary purpose treatment. Start 2018-10-30 (actual); primary completion 2019-11-13 (actual). Results posted on 2020-12-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
- Condition
- Bicuspid Aortic Valve
- Intervention (Device)
- Medtronic TAVR Systems
- Lead sponsor
- Medtronic Cardiovascular
Record details
- Record id
cardio:ct-nct03635424- Content hash
a90b861efb4463bf4714b3d91412f9e29730d9487fa35a855385fd0a60bec2ed